Skip to main content
Clinical Trials/CTRI/2025/02/081483
CTRI/2025/02/081483
Not yet recruiting
Phase 2

Development, Validation and Feasibility testing of Multimodal Early Stimulation Program for Preterm Infants in Neonatal Intensive Care Unit

NA1 site in 1 country38 target enrollmentStarted: March 27, 2025Last updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
NA
Enrollment
38
Locations
1
Primary Endpoint
Feasibility of Multimodal Early Stimulation Program (Adherence rate, acceptance rate, attrition rate, clinical fidelity, ease of performance, deviations from the protocol and adverse events)

Overview

Brief Summary

This study will commence recruiting preterm infants once a panel of experts validates the developed protocol to ensure it is safe to be implemented on the babies. This study will evaluate the feasibility of applying a gestational week-specific comprehensive early stimulation protocol in real-world settings, especially in low and middle-income countries. The findings of this study will help in designing future randomised control trials ensuring quality care

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
1.00 Day(s) to 90.00 Day(s) (—)
Sex
All

Inclusion Criteria

  • Preterm infants born between the gestational age of 26 weeks and 35 weeks APGAR score greater than 7 at birth Haemodynamically stable preterm infants.

Exclusion Criteria

  • Congenital anomalies Invasive ventilation Parents not willing to participate in the study Retinopathy of prematurity Bone fracture Intraventricular haemorrhage.

Outcomes

Primary Outcomes

Feasibility of Multimodal Early Stimulation Program (Adherence rate, acceptance rate, attrition rate, clinical fidelity, ease of performance, deviations from the protocol and adverse events)

Time Frame: Every 7th day. From enrollment to discharge | Baseline and endline will be taken

Secondary Outcomes

  • Content Validity of the developed protocol (Multimodal Early Stimulation Program)(2 weeks)

Investigators

Sponsor
NA
Sponsor Class
Other [na]
Responsible Party
Principal Investigator
Principal Investigator

Abishek J R

SRM College of Physiotherapy, SRM Institute of Science and Technology

Study Sites (1)

Loading locations...

Similar Trials